Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
National
Jonel Aleccia

Foundayo: All you need to know about the newly approved weight-loss pill

Federal regulators have granted expedited approval to Eli Lilly’s new weight-loss pill, Foundayo, establishing it as the second daily oral medication for obesity and related conditions.

The drug, orforglipron, is a GLP-1 medication. It mimics a natural hormone controlling appetite and fullness, similar to widely used injectable treatments. Shipments of Foundayo are set to begin this Monday.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.